IP Library Granted Patent US 6,849,459
Granted Patent B2
US 6,849,459 · App. 10/328,931 · Granted Feb 1, 2005

Microfluidic chip for biomolecule crystallization

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,849,459
App. No.
10/328,931
Granted
Feb 1, 2005
Kind
B2
Abstract

A system for crystallizing a protein and other biomolecules comprises a flow channel for conveying a solution containing the biomolecule to be crystallized and one or more substations related to the crystallization process formed along the flow channel. The system operates by flowing a biomolecule solution through a the flow channel, then performing dialysis on a micro-scale to set crystallization conditions. After dialysis, the concentration of the biomolecule solution is changed by removing water or solvent from the biomolecule solution to promote formation of crystals in a segment of the flow channel. Formed crystals may be observed and harvested from the flow channel.

Claims (17)

1. A method of crystallizing a biomolecule, comprising the steps of:

providing a biomolecule microchannel, comprising an inlet and an outlet;

providing a first filter chamber in a fluid communication with the biomolecule microchannel and located between the inlet and the outlet, the first filter chamber comprising a membrane, wherein the membrane forms one of the sides of the first filter chamber;

providing a buffer microchannel, comprising an inlet and an outlet;

providing a second filter chamber in a fluid communication with the buffer microchannel, the second filter chamber located between the inlet and the outlet of the buffer microchannel and separated from the first filter chamber by said membrane;

flowing a biomolecule solution containing the biomolecule through the biomolecule microchannel and the first filter chamber;

flowing the buffer solution through the buffer microchannel and the second filter chamber;

wherein the biomolecule solution in the first filter chamber is dialyzed through the membrane when in contact with the buffer solution in the second filter chamber; and

a crystal of the biomolecule is formed in the dialyzed biomolecule solution.

2. The method of claim 1 , wherein the step of dialyzing the biomolecule solution sets effectors in the biomolecule solution to promote crystallization of the biomolecule.

3. The method of claim 2 , wherein the effectors comprise ions exchanged through the membrane.

4. The method of claim 2 , wherein the effectors comprise the pH of the biomolecule solution.

5. The method of claim 2 , wherein the effectors comprise the temperature of the biomolecule solution.

6. The method of claim 2 , wherein the effectors comprise detergents that are exchanged with the biomolecule solution through the membrane.

7. The method of claim 1 , further comprising the step of observing the crystal formation.

8. The method of claim 1 , further comprising the step of harvesting the crystal formed during observation.

9. The method of claim 1 , further comprising the step of freezing the crystal for x-ray diffraction.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2021
From: BBVA USA, FORMERLY KNOWN AS COMPASS BANK
To: CYTONOME/ST, LLC
Reel/Frame 055648/0553 →
SECURITY INTEREST Recorded Mar 24, 2015
From: CYTONOME/ST, LLC
To: COMPASS BANK
Reel/Frame 035310/0670 →
CONFIRMATORY ASSIGNMENT Recorded Nov 17, 2009
From: CYTONOME, INC.
To: CYTONOME/ST, LLC
Reel/Frame 023525/0158 →
SECURITY AGREEMENT Recorded Jul 2, 2005
From: CYTONOME, INC.
To: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
Reel/Frame 016216/0145 →